Imaging of neuroleptic occupancy in schizophrenia

By Kerwin R.   Pilowsky L.   Busatto G.   Costa D.   Ell P.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 164-164

Elsevier

Access to resources Recommend Favorite

Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome

By  

Current Pharmacogenomics, Vol. 4, Iss. 2, 2006-01 ,pp. : 113-119

Bentham Science Publishers

Access to resources Recommend Favorite

Limitations in the effectiveness of antipsychotics in schizophrenia

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Long term side effects in schizophrenia outpatients under neuroleptic treatment

By Chinchilla A.   Vega M.   Cebollada A.   Padiacute n J.J.   Diacute az M.   Guzmaacute n G.   Montes J.M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 344-344

Elsevier

Access to resources Recommend Favorite

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

By Petrakis Ismene   O’Malley Stephanie   Rounsaville Bruce   Poling James   McHugh-Strong Colette   Krystal John  

Psychopharmacology, Vol. 172, Iss. 3, 2004-03 ,pp. : 291-297

Springer Publishing Company

Access to resources Recommend Favorite